Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4 ...
Frontiers | POF (paclitaxel/oxaliplatin/5-fluorouracil/leucovorin) vs. SOX/CAPOX/FOLFOX as a postoperative adjuvant chemotherapy for curatively resected stage III gastric cancer: Study protocol for a randomized controlled trial, FNF-014 trial
PDF) ESOPEC: Prospective randomized controlled multicenter phase III trial comparing perioperative chemotherapy (FLOT protocol) to neoadjuvant chemoradiation (CROSS protocol) in patients with adenocarcinoma of the esophagus (NCT02509286)
Systematic review and meta-analysis of docetaxel perioperative chemotherapy regimens in gastric and esophagogastric tumors | Scientific Reports
2038-Gastric and gastroesophageal neoadjuvant/adjuvant FLOT | eviQ
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer | Nature Communications
Gastric cancer - The Lancet
Neoadjuvant FLOT versus SOX phase II randomized clinical trial for patients with locally advanced gastric cancer | Nature Communications
What is the reference cytotoxic regimen in advanced gastric cancer? Florian Lordick Klinikum Braunschweig Germany. - ppt download
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a ...
Perioperative treatment in resectable gastric cancer with spartalizumab in combination with fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT): a phase II study (GASPAR) | BMC Cancer | Full Text
Gastrointestinal cancers: new standards of care from landmark trials | MDedge Hematology and Oncology
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a ...
Feasibility of perioperative chemotherapy with infusional 5-FU, leucovorin, and oxaliplatin with (FLOT) or without (FLO) docetaxel in elderly patients with locally advanced esophagogastric cancer | British Journal of Cancer
NEO- AND ADJUVANT TREATMENT FOR GASTRIC CANCER: THE ROLE OF CHEMOTHERAPY
Cancers | Free Full-Text | Triplet Chemotherapy with Cisplatin versus Oxaliplatin in the CRITICS Trial: Treatment Compliance, Toxicity, Outcomes and Quality of Life in Patients with Resectable Gastric Cancer
The feasibility of triple-drug chemotherapy combination in older adult patients with oesophagogastric cancer: A randomised trial of the Arbeitsgemeinschaft Internistische Onkologie (FLOT65+) - ScienceDirect
Impact of perioperative chemotherapy on postoperative morbidity after gastrectomy for gastric cancer | Cirugía Española
Trial schema. Patients with resectable adenocarcinoma of the... | Download Scientific Diagram
ASCO Review 2017: Non-Colorectal GI | UPMC
Frontiers | VESTIGE: Adjuvant Immunotherapy in Patients With Resected Esophageal, Gastroesophageal Junction and Gastric Cancer Following Preoperative Chemotherapy With High Risk for Recurrence (N+ and/or R1): An Open Label Randomized Controlled Phase-2 ...
